New Zealand-based biotechnology company Greenlab has joined forces with licenced producer Helius Therapeutics to develop specialised and targeted medicinal cannabis treatments for patients unable to benefit from conventional pharmaceuticals.
New Zealand-based biotechnology company Greenlab has joined forces with licenced producer Helius Therapeutics to develop specialised and targeted medicinal cannabis treatments for patients unable to benefit from conventional pharmaceuticals.